Elevated tau protein level is causally linked to disease pathogenesis; in particular, intraneuronal accumulation of aggregated tau closely correlates with the clinical progression of AD as well as other tauopathies [18, 19]. The gene discussed is MAPT; the disease is Alzheimer disease.